Mapping and targeting of C1ql1-expressing cells in the mouse.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
16 10 2023
16 10 2023
Historique:
received:
17
07
2023
accepted:
16
09
2023
medline:
23
10
2023
pubmed:
17
10
2023
entrez:
16
10
2023
Statut:
epublish
Résumé
The C1Q complement protein C1QL1 is highly conserved in mammals where it is expressed in various tissues including the brain. This secreted protein interacts with Brain-specific Angiogenesis Inhibitor 3, BAI3/ADGRB3, and controls synapse formation and maintenance. C1ql1 is expressed in the inferior olivary neurons that send projections to cerebellar Purkinje cells, but its expression in the rest of the brain is less documented. To map C1ql1 expression and enable the specific targeting of C1ql1-expressing cells, we generated a knockin mouse model expressing the Cre recombinase under the control of C1ql1 regulatory sequences. We characterized the capacity for Cre-driven recombination in the brain and mapped Cre expression in various neuron types using reporter mouse lines. Using an intersectional strategy with viral particle injections, we show that this mouse line can be used to target specific afferents of Purkinje cells. As C1ql1 is also expressed in other regions of the brain, as well as in other tissues such as adrenal glands and colon, our mouse model is a useful tool to target C1ql1-expressing cells in a broad variety of tissues.
Identifiants
pubmed: 37845276
doi: 10.1038/s41598-023-42924-2
pii: 10.1038/s41598-023-42924-2
pmc: PMC10579299
doi:
Substances chimiques
Integrases
EC 2.7.7.-
C1ql1 protein, mouse
0
Complement C1q
80295-33-6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
17563Informations de copyright
© 2023. Springer Nature Limited.
Références
BMC Cancer. 2018 Jan 10;18(1):68
pubmed: 29321030
Trends Immunol. 2004 Oct;25(10):551-61
pubmed: 15364058
Cell Rep. 2015 Feb 10;10(5):820-832
pubmed: 25660030
Science. 2001 Nov 2;294(5544):1117-22
pubmed: 11691998
J Cardiovasc Dev Dis. 2022 Oct 06;9(10):
pubmed: 36286293
Mol Med Rep. 2018 Feb;17(2):3028-3034
pubmed: 29257257
Neuron. 2015 Jan 21;85(2):316-29
pubmed: 25611509
Endocrinology. 2022 Jun 1;163(6):
pubmed: 35560215
Immunobiology. 2007;212(4-5):253-66
pubmed: 17544811
Front Cell Neurosci. 2021 Aug 25;15:713651
pubmed: 34512267
J Chemother. 2021 Nov;33(7):476-485
pubmed: 33825671
Eur J Neurosci. 2011 Nov;34(10):1697-710
pubmed: 22103426
Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2534-9
pubmed: 21262840
Genesis. 2016 Aug;54(8):439-46
pubmed: 27194399
Mol Psychiatry. 2013 Aug;18(8):943-50
pubmed: 23628982
Elife. 2021 Mar 04;10:
pubmed: 33661101
Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5163-8
pubmed: 17360345
Eur J Neurosci. 2010 May;31(9):1606-15
pubmed: 20525073
Cell. 2014 Oct 9;159(2):440-55
pubmed: 25263330
Proc Natl Acad Sci U S A. 2022 May 24;119(21):e2122544119
pubmed: 35588456
BMC Dev Biol. 2001;1:4
pubmed: 11299042